Wednesday, March 23, 2011

Written Testimony Due April 18

Source: US Federal Register
        Volume 76, Number 55, Page 15982
Date:   March 22, 2011
URL:    
http://frwebgate3.access.gpo.gov/cgi-bin/TEXTgate.cgi?WAISdocID=MTDX0H/0/1/0


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Meeting of the Chronic Fatigue Syndrome Advisory Committee
----------------------------------------------------------

AGENCY: Department of Health and Human Services, Office of
the  Secretary, Office of the Assistant Secretary
for Health.

ACTION: Notice.

SUMMARY: As stipulated by the Federal Advisory Committee Act,
the U.S. Department of Health and Human Services is hereby
giving notice that the Chronic Fatigue Syndrome Advisory
Committee (CFSAC) will hold a meeting. The meeting will be
open to the public.

DATES: The meeting will be held on Tuesday and Wednesday,
May 10 and 11, 2011. The meeting will be held from 9 a.m.
until 5 p.m. on May 10, 2011, and 9 a.m. until 4:30 p.m. on
May 11, 2011.

ADDRESSES: Department of Health and Human Services; Room 800,
Hubert H. Humphrey Building; 200 Independence Avenue, SW.,
Washington, DC 20201. For a map and directions to the Hubert
H. Humphrey building, please visit
http://www.hhs.gov/about/hhhmap.html.

FOR FURTHER INFORMATION CONTACT: Wanda K. Jones, DrPH;
Executive Secretary, Chronic Fatigue Syndrome Advisory
Committee, Department of Health and Human Services; 200
Independence Avenue, SW., Hubert Humphrey Building, Room
712E; Washington, DC 20201. Please direct all inquiries
to cfsac@hhs.gov.

SUPPLEMENTARY INFORMATION: CFSAC was established on
September 5, 2002.
The Committee shall advise and make recommendations to
the Secretary, through the Assistant Secretary for Health,
on a broad range of topics including (1) the current state
of knowledge and research and the relevant gaps in
knowledge and research about the epidemiology, etiologies,
biomarkers and risk factors relating to CFS, and
identifying potential opportunities in these areas; (2)
impact and implications of current and proposed diagnosis
and treatment methods for CFS; (3) development and
implementation of programs to inform the public, health
care professionals, and the biomedical academic and
research communities about CFS advances; and (4)
partnering to improve the quality of life of CFS
patients.

The agenda for this meeting is being developed. The agenda
will be posted on the CFSAC Web site,
   http://www.hhs.gov/advcomcfs
when it is finalized. The meeting will be broadcast over
the Internet as a real-time streaming video. It also will
be recorded and archived for on demand viewing through
the CFSAC Web site.

Public attendance at the meeting is limited to space
available.

Individuals must provide a government-issued photo ID for
entry into the building where the meeting is scheduled to
be held. Those attending the meeting will need to sign-in
prior to entering the meeting room.

Individuals who plan to attend and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify the designated contact
person at cfsac@hhs.gov in advance.

Members of the public will have the opportunity to provide
oral testimony at the May 10-11, 2011, meeting if pre-
registered.

Individuals who wish to address the Committee during the
public comment session must pre-register by Monday, April
18, 2011, via e-mail to cfsac@hhs.gov. Time slots for
public comment will be available on a first-come, first-
served basis and will be limited to five minutes per
speaker; no exceptions will be made. Individuals
registering for public comment should submit a copy of
their oral testimony in advance to cfsac@hhs.gov, prior to
the close of business on Monday, April 18, 2011.

If you do not submit your written testimony by the close
of business Monday, April 18, 2011, you may bring a copy
to the meeting and present it to a CFSAC Support Team
staff member. Your testimony will be included in a
notebook available for viewing by the public on a table
at the back of the meeting room.

Members of the public not providing public comment at the
meeting who wish to have printed material distributed to
CFSAC members for review should submit, at a minimum,
one copy of the material to the Executive Secretary, at
cfsac@hhs.gov, prior to close of business on Monday,
April 18, 2011. Submissions are limited to five
typewritten pages. If you wish to remain anonymous,
please notify the CFSAC support team upon submission of
your materials to cfsac@hhs.gov.

All testimony and printed material submitted for the
meeting are part of the official meeting record and will
be uploaded to the CFSAC Web site and made available for
public inspection. Testimony and materials submitted
should not include any sensitive personal information,
such as a person's social security number; date of
birth; driver's license number, State identification
number or foreign country equivalent; passport number;
financial account number; or credit or debit card number.
Sensitive health information, such as medical records or
other individually identifiable health information, or
any non-public corporate or trade association
information, such as trade secrets or other proprietary
information also should be excluded from any materials
submitted.

Dated: March 18, 2011.
Wanda K. Jones,
Executive Secretary, Chronic Fatigue Syndrome Advisory
Committee.
[FR Doc. 2011-6702 Filed 3-21-11; 8:45 am]
BILLING CODE 4150-42-P

--------
(c) 2011 Federal Register

No comments: